Its been 4 years that i have written anything in my blog. but this lockdown has made me come back. Covid 19 has become a pandemic all over the world and will it be a blessing in disguise for Pharma n medical diagnostic companies based out of india , as every where globally countries are finding issues with diagnostics purchased from china.
Elctronic companies based out of south korea and japan are moving their manufacturing out of china, so will this be applicable for Pharma API for which china was the first in terms of production of major API's all across globe, will the big Pharma giants shift their APIs production from china to india ??????
The good part is the drug manufactured for treatment of malaria in the developing nations is one of the key element in covid treatment in the western world, i am talking about hydrochloroquin which is used in combination with broad spectrum antibiotic azithromycin, which i will cover in details in later blogs
Indian generics like Cipla n others would like to work on remdesivir, a orphan status drug which was developed for treatment of Ebola, which till yesterday didnt show any significant effect in severe Covid 19 patients in Phase III clinical trials but they still hope that it may have some effect on moderate Covid 19 patients in P3 trialsa, results are awaited by may first or 2nd week, then indian companies may proceed for the copycat
Another Oxford UK based vaccine trial for Covid 19 has started yesterday and they have collaborated all across globe for clinical trials and have collaborated with Serum institute of india, lets wait for teh results .....
More in the next blog .....happy weekend
Elctronic companies based out of south korea and japan are moving their manufacturing out of china, so will this be applicable for Pharma API for which china was the first in terms of production of major API's all across globe, will the big Pharma giants shift their APIs production from china to india ??????
The good part is the drug manufactured for treatment of malaria in the developing nations is one of the key element in covid treatment in the western world, i am talking about hydrochloroquin which is used in combination with broad spectrum antibiotic azithromycin, which i will cover in details in later blogs
Indian generics like Cipla n others would like to work on remdesivir, a orphan status drug which was developed for treatment of Ebola, which till yesterday didnt show any significant effect in severe Covid 19 patients in Phase III clinical trials but they still hope that it may have some effect on moderate Covid 19 patients in P3 trialsa, results are awaited by may first or 2nd week, then indian companies may proceed for the copycat
Another Oxford UK based vaccine trial for Covid 19 has started yesterday and they have collaborated all across globe for clinical trials and have collaborated with Serum institute of india, lets wait for teh results .....
More in the next blog .....happy weekend
No comments:
Post a Comment